Study on the Synergistic Effect of Klotho and KRAS on Reducing Ferroptosis After Myocardial Infarction by Regulating

ChengZhe Cai1, YiQin Wu1, XiaoQian Feng1

  • 1Department of Internal Medicine-Cardiovascular, Guangzhou Twelfth People's Hospital, No.1, Tianqiang Road, Tianhe District, Guangzhou City, Guangdong Province, 510620, China.

Insights

Klotho protein deficiency exacerbates myocardial infarction (MI) and ferroptosis by promoting oxidative stress. Restoring Klotho function, through interaction with KRAS and regulation of the RAP1/ERK pathway, mitigates MI-induced ferroptosis.

Area of Science:

  • Cardiovascular Biology
  • Cell Death Mechanisms
  • Molecular Medicine

Background:

  • Myocardial infarction (MI) is a leading cause of sudden death, characterized by cardiomyocyte death due to nutrient and oxygen deprivation.
  • Ferroptosis, a form of regulated cell death driven by metabolic dysfunction and iron-dependent reactive oxygen species (ROS) accumulation, is implicated in MI pathogenesis.
  • The roles of Klotho and KRAS in MI-associated ferroptosis remain largely undefined.

Purpose of the Study:

  • To elucidate the molecular mechanisms of ferroptosis in myocardial infarction (MI).
  • To investigate the functional roles of Klotho and KRAS in ferroptosis during MI.
  • To explore the interaction between Klotho and KRAS and their regulation of the RAP1/ERK pathway in MI.

Main Methods:

  • Established MI rat models via LAD ligation and an in vitro oxygen-glucose deprivation (OGD) model using H9c2 cells.
  • Assessed myocardial injury, apoptosis, and ferroptosis markers (e.g., ROS, GSH, LDH, CK-MB, cTnT, PTGS2) using histological staining, Western Blot, RT-qPCR, IHC, CCK-8, and ELISA assays.
  • Investigated Klotho-KRAS interaction via co-immunoprecipitation and Western Blot; analyzed the RAP1/ERK pathway.

Main Results:

  • Klotho was downregulated in MI, and its deficiency aggravated myocardial injury, cardiomyocyte apoptosis, and ferroptosis.
  • Klotho deficiency increased ROS and pro-ferroptotic markers while decreasing antioxidant GSH levels.
  • Klotho and KRAS exhibited an endogenous interaction; KRAS knockdown reversed Klotho knockdown-induced MI and ferroptosis. Inhibition of the RAP1/ERK pathway counteracted KRAS-mediated MI progression and ferroptosis.

Conclusions:

  • Klotho interacts with KRAS and plays a protective role against ferroptosis in myocardial infarction.
  • Klotho inhibits MI-induced ferroptosis by regulating the RAP1/ERK signaling pathway.
  • Targeting the Klotho-KRAS-RAP1/ERK axis presents a potential therapeutic strategy for managing myocardial infarction.